Chemical Compound

Inavolisib

CAS Registry Number 2060571-02-8
Inavolisib chemical structure
Primary Record

Inavolisib

In stock
4,120 g
Purity
98.7 %
CAS
2060571-02-8

Compound Identifiers & Properties

CAS
2060571-02-8
PubChem CID
124173720
SMILES
C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F
Canonical SMILES
C[C@H](Nc1ccc2c(c1)OCCn1cc(N3C(=O)OC[C@H]3C(F)F)nc1-2)C(N)=O

Names & Synonyms

  • Inavolisib
  • GDC-0077
  • Itovebi
  • 2060571-02-8
  • Inavolisib [USAN]
  • Itovebi (TN)
  • L4C1UY2NYH
  • GDC0077
  • RG6114
  • INAVOLISIB [INN]
  • Inavolisib (USAN/INN)
  • RefChem:148062
  • UNII-L4C1UY2NYH
  • Ro7113755
  • INAVOLISIB [WHO-DD]
  • MFCD31382124
  • PI3K Inhibitor GDC0077
  • SGEUNORSOZVTOL-CABZTGNLSA-N
  • GTPL9636
  • orb1308276
  • CHEMBL4650215
  • GDC 0077
  • SCHEMBL18360780
  • SCHEMBL29695471
  • RG-6114
  • C18H19F2N5O4
  • BDBM295665
  • DTXSID101358744
  • GLXC-24203
  • AMY16810
  • EX-A2685
  • RG 6114
  • GDC-0077?
  • NSC800729
  • s8668
  • US10112932, Compound 101
  • WHO 11204
  • RO-7113755
  • AKOS040741785
  • ZINC669678973
  • ACN-053209
  • AT36699
  • CS-6459
  • DB15275
  • GDC-0077; RG6114
  • NSC-800729
  • AC-31594
  • BP-43656
  • MS-26989
  • SY235756
  • HY-101562
  • RO 7113755
  • D11942
  • A903455
  • (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide
  • GDC-0077;RG6114;RO-7113755
  • (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
  • B2693-007357
  • (2S)-2-[[2-[(4S)-4-(Difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
  • N~2~-{(4S,11aP)-2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-alaninamide
  • Propanamide, 2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)-, (2S)-
  • (2S)-2-((2-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)propanamide
  • (2S)-2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-3-OXAZOLIDINYL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)PROPANAMIDE
  • (2S)-2-((4-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-9-oxa-3,6-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),2,4,10,12-pentaen-12-yl)amino)propanamide
  • (2S)-2-({2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)propanamide
  • (2S)-2-({4-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0(2),?]tetradeca-1(14),2,4,10,12-pentaen-12-yl}amino)propanamide
  • (2S)-2-({4-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0,tetradeca-1(14),2,4,10,12-pentaen-12-yl}amino)propanamide
  • (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
  • (S)-2-((2-((S)-4-(difluoromethyl)- 2-oxooxazolidin-3-yl)-5,6- dihydrobenzo[f]imidazo[1,2- d][1,4]oxazepin-9- yl)amino)propanamide
  • (S)-2-((2-((S)-4-(Difluoromethyl)-2-oxooxaZolidin-3-yl)-5,6-dihydrobenZo[f]imidaZo[1,2-d][1,4]oxaZepin-9-yl)propanamide
  • (S)-2-[[2-[(S)-4-(Difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]amino]propanamide
  • Propanamide, 2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]-, (2S)-
  • X3N